Down’s, Edwards' and Patau's syndrome screening: non invasive prenatal testing

This statement explains the NHS fetal anomaly screening programme (FASP) position on non-invasive prenatal testing (NIPT).


Frequently asked questions: cell free fetal DNA (cffDNA) testing for Down’s, Edwards' and Patau's syndrome and other trisomies

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This statement explains the current availability in the NHS of non-invasive prenatal screening for Down’s, Edwards’ and Patau’s syndrome.

The publication also includes information about the ongoing research testing whether the procedure is a viable option for NHS population screening.

Published 1 January 2013